SMEs can apply for a share of £1 million to support the evaluation of innovative medical devices, diagnostics and regulated digital health products.
Programme: The Office for Life Sciences (OLS) in partnership with Innovate UK
Opens: 29th Jan 2018
Closes: 21st Mar 2018
The Office for Life Sciences (OLS) in partnership with Innovate UK is to invest up to £1 million to support developers of innovative medicines, medical devices, diagnostics and regulated digital technology to evaluate their product in a real world clinical setting.
This competition aims to provide support for small and medium-sized enterprises (SMEs) to generate an evidence base that will enable the evaluation of products that address NHS priorities. This support is intended to allow companies to collect and analyse clinical performance and cost effectiveness data within an NHS setting.
This competition will also fund projects that support the development or design of plans for the collection of clinical data.
Priority will be given to products that address the priorities outlined in the next steps on the NHS 5 year forward view. Developers of medical devices, diagnostics and regulated digital healthcare products should have gained a CE marking. However, you should not have marketed the product in the UK for more than 5 years.
You will need to show how your product is likely to have a significant impact and is aligned with NHS England’s priorities.
You should show how your project will produce evidence of the impact of your technology, and where appropriate increase patient access to innovative technologies.
Priority will be given to projects that address:
Applications should also demonstrate how the project will:
To apply for funding you must:
SMEs may work alone or in collaboration with other businesses or research organisations as unfunded partners or sub-contractors. Only the SME leading the project can claim grant.
Total project costs must range in size from £50k to £250k.
Funding and project details
Option 1: project costs of up to £50k
SMEs can apply for support to develop detailed and feasible plans for the collection of relevant data in a clinical setting. It is expected that the development of these plans will involve discussion with appropriate stakeholders in NIHR, NICE and NHS England.
Option 2: project costs of up to £250k
SMEs can apply for support to enable the collection and analysis of real world data that helps evaluate the impact of your product. Plans must have been developed in discussion with NICE and NHS England.
Projects should focus on understanding evidence gaps, and testing product performance to elucidate the operational impact of your product on NHS service provision.
You could get funding of up to 50% of your eligible project costs.